UB Paderborn / Katalog / Suche / in CDI

Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers

The New England journal of medicine, 2011-06, Vol.364 (23), p.2199-2207

2011

Link zum Volltext

Verfügbarkeit prüfen

Expanding access to hepatitis C virus treatment—Extension for Community Healthcare Outcomes (ECHO) project: Disruptive innovation in specialty care

Hepatology (Baltimore, Md.), 2010-09, Vol.52 (3), p.1124-1133

2010

Link zum Volltext

Verfügbarkeit prüfen

Telehealth and hepatitis C treatment for indigenous communities in the United States

Revista panamericana de salud pública, 2020-01, Vol.44 (13), p.e13-e13

2020

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus infection

JAACP : Journal of the American College of Clinical Pharmacy, 2018-10, Vol.1 (1), p.46-49

Deming, Paulina

2018

Link zum Volltext

Verfügbarkeit prüfen

1073. The Time is Now for Rapid Initiation of Hepatitis C Virus (HCV) Treatment

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S564-S564

2020

Link zum Volltext

Verfügbarkeit prüfen

Partnering urban academic medical centers and rural primary care clinicians to provide complex chronic disease care

Health affairs (Millwood, Va.), 2011-06, Vol.30 (6), p.1176

2011

Link zum Volltext

Verfügbarkeit prüfen

Taribavirin in the treatment of hepatitis C

Expert opinion on investigational drugs, 2011-10, Vol.20 (10), p.1435-1443

2011

Link zum Volltext

Verfügbarkeit prüfen

Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection

Pharmacotherapy, 2017-06, Vol.37 (6), p.735-747

2017

Link zum Volltext

Verfügbarkeit prüfen

2503. Re-engagement in Care for Patients with Positive Hepatitis C Virus Antibody Test: A Descriptive Study at a Large University Hospital

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs

Journal of viral hepatitis, 2024-06, Vol.31 (6), p.342-356

2024

Link zum Volltext

Verfügbarkeit prüfen

Telehealth and hepatitis C treatment for indigenous communities in the United States

Revista panamericana de salud pública, 2020, Vol.44

2020

Link zum Volltext

Verfügbarkeit prüfen

Telehealth and hepatitis C treatment for indigenous communities in the United States

Revista panamericana de salud pública, 2020-01, Vol.44

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of patients with HIV or hepatitis C by pharmacist clinicians in a patient-centered medical home

American journal of health-system pharmacy, 2019-05, Vol.76 (11), p.821-828

2019

Link zum Volltext

Verfügbarkeit prüfen

Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2386-2392

2011

Link zum Volltext

Verfügbarkeit prüfen

Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives

Open forum infectious diseases, 2019-07, Vol.6 (7), p.ofz128-ofz128

2019

Link zum Volltext

Verfügbarkeit prüfen

Provision of Clinical Pharmacist Services for Individuals With Chronic Hepatitis C Viral Infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy

Pharmacotherapy, 2014-12, Vol.34 (12), p.1341-1354

2014

Link zum Volltext

Verfügbarkeit prüfen

Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus: Challenges and Therapeutic Advances: Insights from the Society of Infectious Diseases Pharmacists

Pharmacotherapy, 2011-04, Vol.31 (4), p.357-368

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Liver Biomarkers as Prognostic Factors for Outcomes to Yttrium-90 Radioembolization of Primary and Secondary Liver Malignancies

Cancer biotherapy & radiopharmaceuticals, 2015-09, Vol.30 (7), p.305

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists

Pharmacotherapy, 2016-02, Vol.36 (2), p.203-217

2016

Link zum Volltext

Verfügbarkeit prüfen

Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus: Challenges and Therapeutic Advances

Pharmacotherapy, 2011-04, Vol.31 (4), p.357-368

2011

Link zum Volltext

Verfügbarkeit prüfen

Provision of Clinical Pharmacist Services for Individuals With Chronic Hepatitis C Viral Infection

Pharmacotherapy, 2014-12, Vol.34 (12), p.1341-1354

2014

Link zum Volltext

Verfügbarkeit prüfen

Catatonia Associated with Pegylated Interferon-α 2b and Ribavirin for Hepatitis C

Psychosomatics (Washington, D.C.), 2012-07, Vol.53 (4), p.400-401

2012

Link zum Volltext

Verfügbarkeit prüfen

Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment

Hepatology international, 2016-07, Vol.10 (4), p.624-631

2016

Link zum Volltext

Verfügbarkeit prüfen

Project ECHO: a Revolutionary Approach to Expanding Access to Modern Treatments for Hepatitis C

Current hepatology reports, 2016-09, Vol.15 (3), p.178-186

2016

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Hepatitis C Treatment by Primary Care Providers

The New England journal of medicine, 2011-06, Vol.364 (23)

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers

Expanding access to hepatitis C virus treatment—Extension for Community Healthcare Outcomes (ECHO) project: Disruptive innovation in specialty care

Telehealth and hepatitis C treatment for indigenous communities in the United States

Hepatitis C virus infection

1073. The Time is Now for Rapid Initiation of Hepatitis C Virus (HCV) Treatment

Partnering urban academic medical centers and rural primary care clinicians to provide complex chronic disease care

Taribavirin in the treatment of hepatitis C

Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection

2503. Re-engagement in Care for Patients with Positive Hepatitis C Virus Antibody Test: A Descriptive Study at a Large University Hospital

Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs

Telehealth and hepatitis C treatment for indigenous communities in the United States

Telehealth and hepatitis C treatment for indigenous communities in the United States

Treatment of patients with HIV or hepatitis C by pharmacist clinicians in a patient-centered medical home

Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia

Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives

Provision of Clinical Pharmacist Services for Individuals With Chronic Hepatitis C Viral Infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy

Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus: Challenges and Therapeutic Advances: Insights from the Society of Infectious Diseases Pharmacists

Evaluation of Liver Biomarkers as Prognostic Factors for Outcomes to Yttrium-90 Radioembolization of Primary and Secondary Liver Malignancies

Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists

Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus: Challenges and Therapeutic Advances

Provision of Clinical Pharmacist Services for Individuals With Chronic Hepatitis C Viral Infection

Catatonia Associated with Pegylated Interferon-α 2b and Ribavirin for Hepatitis C

Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment

Project ECHO: a Revolutionary Approach to Expanding Access to Modern Treatments for Hepatitis C

Outcomes of Hepatitis C Treatment by Primary Care Providers

Suchergebnisse filtern